Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom

BACKGROUND: The adoption of quadrivalent influenza vaccine (QIV) to replace trivalent influenza vaccine (TIV) in immunization programs is growing worldwide, thus helping to address the problem of influenza B lineage mismatch. However, the price per dose of QIV is higher than that of TIV. In such cir...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Infect Dis
Main Authors: Thommes, Edward W., Ismaila, Afisi, Chit, Ayman, Meier, Genevieve, Bauch, Christopher T.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623926/
https://ncbi.nlm.nih.gov/pubmed/26503131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-015-1193-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares